| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
* Laboratory of Immunoregulation, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD 20892;
SAIC Frederick, Inc., AIDS Monitoring Laboratory, Frederick, MD 21702; and
Center for Biologics Research and Evaluation, U.S. Food and Drug Administration, Bethesda, MD 20892
Resting CD4+ T cells containing integrated HIV provirus constitute one of the long-lived cellular reservoirs of HIV in vivo. This cellular reservoir of HIV had been thought to be quiescent with regard to virus replication based on the premise that HIV production in T cells is inexorably linked to cellular activation as determined by classical activation markers. The transition of T cells within this HIV reservoir from a resting state to an activated HIV-producing state is believed to be associated with a shorten life span due to susceptibility to activation-associated apoptosis. Evidence is mounting, however, that HIV production may occur in T cells that have not undergone classic T cell activation. HIV encodes several proteins, including envelope and Nef, which trigger a variety of signaling pathways associated with cellular activation, thereby facilitating HIV replication in nondividing cells. The present study demonstrates that production of infectious virus from resting CD4+ T cells isolated from HIV-infected individuals can be induced following exposure of these cells to HIV-1 recombinant (oligomeric gp140) envelope protein. Envelope-mediated induction of HIV expression occurs in the presence of reverse transcriptase inhibitors and is not associated with markers of classic T cell activation, proliferation, or apoptosis. The ability of HIV envelope to induce virus replication in HIV-infected resting CD4+ T cells without triggering apoptosis provides a mechanism for the virus itself to directly participate in the maintenance of HIV production from this cellular reservoir.
This article has been cited by other articles:
|
|
 |
|
  P. Kaiser, B. Joos, B. Niederost, R. Weber, H. F. Gunthard, M. Fischer, and the Swiss HIV Cohort Study Productive Human Immunodeficiency Virus Type 1 Infection in Peripheral Blood Predominantly Takes Place in CD4/CD8 Double-Negative T Lymphocytes J. Virol., September 15, 2007; 81(18): 9693 - 9706. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C. Cicala, J. Arthos, E. Martinelli, N. Censoplano, C. C. Cruz, E. Chung, S. M. Selig, D. Van Ryk, J. Yang, S. Jagannatha, et al. R5 and X4 HIV envelopes induce distinct gene expression profiles in primary peripheral blood mononuclear cells PNAS, March 7, 2006; 103(10): 3746 - 3751. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
W. J. Swiggard, C. Baytop, J. J. Yu, J. Dai, C. Li, R. Schretzenmair, T. Theodosopoulos, and U. O'Doherty Human Immunodeficiency Virus Type 1 Can Establish Latent Infection in Resting CD4+ T Cells in the Absence of Activating Stimuli J. Virol., November 15, 2005; 79(22): 14179 - 14188. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
Y. Zhou, H. Zhang, J. D. Siliciano, and R. F. Siliciano Kinetics of Human Immunodeficiency Virus Type 1 Decay following Entry into Resting CD4+ T Cells J. Virol., February 15, 2005; 79(4): 2199 - 2210. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
W. Fitzgerald, A. W. Sylwester, J.-C. Grivel, J. D. Lifson, and L. B. Margolis Noninfectious X4 but Not R5 Human Immunodeficiency Virus Type 1 Virions Inhibit Humoral Immune Responses in Human Lymphoid Tissue Ex Vivo J. Virol., July 1, 2004; 78(13): 7061 - 7068. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C. Lee, Q.-H. Liu, B. Tomkowicz, Y. Yi, B. D. Freedman, and R. G. Collman Macrophage activation through CCR5- and CXCR4-mediated gp120-elicited signaling pathways J. Leukoc. Biol., November 1, 2003; 74(5): 676 - 682. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. G. Brooks, P. A. Arlen, L. Gao, C. M. R. Kitchen, and J. A. Zack Identification of T cell-signaling pathways that stimulate latent HIV in primary cells PNAS, October 28, 2003; 100(22): 12955 - 12960. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
